Clinical Trial Update: Immune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTE

View source ↗

Summary

A clinical trial evaluating immune profiling in children with refractory childhood-onset systemic lupus erythematosus after exposure to a CD3×CD19 bispecific T …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Childhood-onset Systemic Lupus Erythematosus

Drugs mentioned

• BLINCYTO (BLINATUMOMAB)

Snippet

Sponsor: The Children's Hospital of Zhejiang University School of Medicine | Conditions: Childhood-onset Systemic Lupus Erythematosus | Status: RECRUITING